Sanofi US (FKA Sanofi-Aventis)
Registered Principal Details
Business Or Interest:
Pharmaceutical Manufacturing
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Paul Hudson
Head
Pharmaceutical Manufacturing
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Paul Hudson
Head
Contact
DC
Deanne Calvert
1122 E. Pike Street, #1002
Seattle, WA 98122
(206) 320-0536
deanne.calvert@sanofi.com
http://www.sanofi.us
1122 E. Pike Street, #1002
Seattle, WA 98122
(206) 320-0536
deanne.calvert@sanofi.com
http://www.sanofi.us
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 552
Relating to: cost-sharing cap on insulin.
Bill Text and History
9/15/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: cost-sharing cap on insulin.
Bill Text and History
For
Notification Date9/15/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Joint Resolution 29
Relating to: proclaiming March 2021 to be Kidney Month in Wisconsin.
Bill Text and History
4/29/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: proclaiming March 2021 to be Kidney Month in Wisconsin.
Bill Text and History
For
Notification Date4/29/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Resolution 12
Relating to: observing February 28, 2021, as Rare Disease Day in Wisconsin.
Bill Text and History
3/9/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: observing February 28, 2021, as Rare Disease Day in Wisconsin.
Bill Text and History
For
Notification Date3/9/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Resolution 24
Relating to: observing February 28, 2022, as Rare Disease Day in Wisconsin.
Bill Text and History
2/2/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: observing February 28, 2022, as Rare Disease Day in Wisconsin.
Bill Text and History
For
Notification Date2/2/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 215
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 546
Relating to: cost-sharing cap on insulin.
Bill Text and History
9/15/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: cost-sharing cap on insulin.
Bill Text and History
For
Notification Date9/15/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Resolution 4
Relating to: observing February 28, 2021, as Rare Disease Day.
Bill Text and History
2/17/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: observing February 28, 2021, as Rare Disease Day.
Bill Text and History
For
Notification Date2/17/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
2/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
2/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Wisconsin Economic Development Corporation
Wisconsin Economic Development Corporation
Notification Date
2/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
2/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Wisconsin Economic Development Corporation
Wisconsin Economic Development Corporation
Notification Date
2/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
2/22/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Administrative Rulemaking Proceedings
Agency Name
Department of Health Services (DHS)
Subject
Screening newborns for congenital and metabolic disorders
Scope Statement
SS 148_20
2/14/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Department of Health Services (DHS)
Subject
Screening newborns for congenital and metabolic disorders
Scope Statement
SS 148_20
For
Notification Date2/14/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
2023-25 Biennial Budget Bill
2023-25 Biennial Budget Bill
Action Intended To Affect
Both Legislative matter and rule
Notification Date
10/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
10/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmaceuticals pricing
Pharmaceuticals pricing
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Biosimilars
Biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Meningococcal vaccine school entry requirement recommendations
Meningococcal vaccine school entry requirement recommendations
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
2019-21 State Budget Bill
2019-21 State Budget Bill
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
The availability of the flu vaccine in hospitals and nursing homes
The availability of the flu vaccine in hospitals and nursing homes
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Health and immunization standards
Health and immunization standards
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
Development, drafting or introduction of a proposal relating to
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Prevention and wellness initiatives
Prevention and wellness initiatives
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Development, drafting or introduction of a proposal relating to
Step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
All matters related to funding and regulatory changes in response to COVID 19
All matters related to funding and regulatory changes in response to COVID 19
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Vaccines and Immunizations
Vaccines and Immunizations
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
2021-23 Biennial Budget Bill
2021-23 Biennial Budget Bill
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
All matters related to insulin pricing
All matters related to insulin pricing
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to newborn screening
Matters related to newborn screening
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/21/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 January - June $12,907.12 |
2021 July - December $16,341.50 |
2022 January - June $14,631.00 |
2022 July - December $14,531.70 |
Total $58,411.32 |
| Total Hours Communicating | 2021 January - June 8.80 |
2021 July - December 9.85 |
2022 January - June 1.30 |
2022 July - December 3.20 |
Total 23.15 |
| Total Hours Other | 2021 January - June 57.90 |
2021 July - December 22.25 |
2022 January - June 24.05 |
2022 July - December 34.40 |
Total 138.60 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 15% |
2021 July - December 30% |
2022 January - June 35% |
2022 July - December 50% |
Total 30% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 15% |
2021 July - December 30% |
2022 January - June 35% |
2022 July - December 50% |
Total 30% |
Relating to: cost-sharing cap on insulin.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 15% |
2022 January - June 10% |
2022 July - December |
Total 5% |
Relating to: cost-sharing cap on insulin.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 15% |
2022 January - June 10% |
2022 July - December |
Total 5% |
Relating to: observing February 28, 2022, as Rare Disease Day in Wisconsin.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 10% |
2022 July - December |
Total 2% |
Budget Bill Subjects
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 20% |
2021 July - December |
2022 January - June |
2022 July - December |
Total 8% |
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 10% |
2021 July - December |
2022 January - June |
2022 July - December |
Total 4% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 10% |
2021 July - December |
2022 January - June |
2022 July - December |
Total 4% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 10% |
2021 July - December 5% |
2022 January - June |
2022 July - December |
Total 5% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June 20% |
2021 July - December |
2022 January - June |
2022 July - December |
Total 8% |
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 5% |
2022 January - June |
2022 July - December |
Total < 1% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.